pablorojo.bsky.social @pablorojo.bsky.social · 28/07/2026We believe it is an important article to focus on CMV in patients living with HIV. Thank you @thelancet.com for supporting the work. Such a terrible association in infants: HIV and CMV!! 010
pablorojo.bsky.social @pablorojo.bsky.social · 20/07/2026At @globalpid.bsky.social we are very happy with the publication!! it gives hope to infants living with HIV and pneumonia and all children living with HIV advanced disease! @pentafoundation.bsky.social was fundamental to push the trial and many African and European partners were involved! 111
pablorojo.bsky.social @pablorojo.bsky.social · 22/05/2026TEAM COACH is a great tool for training on IPC and AMS! @globalpid.bsky.social great effort led by Dra. Cristina Epalza! Contact us if you are interested ; ) 000
pablorojo.bsky.social @pablorojo.bsky.social · 19/03/2026⭐ Excited to be attending #ESPID2026 in Bologna & online! Looking forward to connecting with colleagues & exploring the latest in paediatric infectious diseases. There’s still time to register! Join me: invt.io/1bxbiwmw8frinvt.ioI'm Attending ESPID 2026!You can still register and save. Let's meet there! 021
Reposted by @pablorojo.bsky.socialInnovation in Global Pediatric Infectious Diseases @globalpid.bsky.social · 03/02/2026Day 1 ✔️ #ENABLE project kicks-off today to prepare our clinical trial using #bNAbs to treat infants living with #HIV 👶🏽💙 Such a good start—strong ideas, great people, big goals 🚀 @globalhealthedctp3.bsky.social #EDCTP3 165
pablorojo.bsky.social @pablorojo.bsky.social · 01/12/2025Indeed at @globalpid.bsky.social we want to keep the fight against HIV in children. Great advances have occurred but still a need for improvement in pediatric #HIV 020
Reposted by @pablorojo.bsky.socialInnovation in Global Pediatric Infectious Diseases @globalpid.bsky.social · 26/11/2025Yesterday, our colleages Irati and Cristina presented at #Gesida25 📊 Their work highlights the continued commitment of our team to advancing knowledge and driving impactful change in the field of #HIV ⚕️ Congratulations to both for their excellent contributions! @gesida-seimc.bsky.social 053
pablorojo.bsky.social @pablorojo.bsky.social · 03/10/2025We need more research on hospital discharge in children living with #HIV. Follow www.supportproject.eu @globalhealthedctp3.bsky.social funded project!supportproject.euSupport project 010
Reposted by @pablorojo.bsky.socialInnovation in Global Pediatric Infectious Diseases @globalpid.bsky.social · 25/09/2025Meet our #SUPPORT colleague Ssegawa Abdulkarim and his project: the development of an innovative #telemedicine app to monitor children’s respiratory #health 🫁 It will be an invaluable tool, especially in communities with limited resources! #Paediatrics #ChildCare #AI youtu.be/_AVueJ_EtcI?...youtu.beUsing AI to detect early signs of respiratory failure and save lives after hospital dischargeYouTube video by Penta Child Health Research 181
pablorojo.bsky.social @pablorojo.bsky.social · 04/09/2025Great to progress on Pediatric Advanced HIV disease training. Mortality is so high, we need to implement better and do more research! @pentafoundation.bsky.social @unitaid.bsky.social 020
pablorojo.bsky.social @pablorojo.bsky.social · 23/07/2025Advanced HIV disease continues to drive mortality in children living with HIV so very important to improve knowledge through #THRIVE 030
Reposted by @pablorojo.bsky.socialInnovation in Global Pediatric Infectious Diseases @globalpid.bsky.social · 18/07/2025A paediatrician’s journey from clinic to cure: our colleage Alfredo Tagarro shares his story with the #EPIICAL study and how it is reshaping #HIV research for #children 👶 A story of science, hope, and global collaboration 🌍❤️ 📖 Read more: penta-id.org/scientific/m... @pentafoundation.bsky.socialpenta-id.orgMy EPIICAL journey: a quest for a cure and a testament to collaboration | Penta"The HIV pandemic continues to impact children around the world, and it’s our ethical and scientific duty to seek not just treatment, but a cure. EPIICAL has put the spotlight on some very important p... 072
pablorojo.bsky.social @pablorojo.bsky.social · 14/07/2025Great work, MITs collaboration with @isglobal.org and @pentafoundation.bsky.social 010
pablorojo.bsky.social @pablorojo.bsky.social · 14/07/2025Thank you Alfredo Tagarro and Kavidha Reddy for presenting on #EARTHcohort at #IAS25 #pediatrics. Great @pentafoundation.bsky.social results! 010
pablorojo.bsky.social @pablorojo.bsky.social · 11/07/2025It is a very important meeting, we will present results from the #EMPIRICAL Trial, @pentafoundation.bsky.social SHIELD trial and #EPIICAL results! 010
pablorojo.bsky.social @pablorojo.bsky.social · 11/07/2025It is a very important meeting, we will present results from the #EMPIRICAL Trial, @pentafoundation.bsky.social SHIELD trial and #EPIICAL results! 041
pablorojo.bsky.social @pablorojo.bsky.social · 24/06/2025THRIVE is a very important project on Advanced HIV Disease, Penta is leading the implementation research in pediatrics! 010
Reposted by @pablorojo.bsky.socialInnovation in Global Pediatric Infectious Diseases @globalpid.bsky.social · 29/05/2025🎓Yesterday, our colleage Serena Villaverde presented our project Team-COACH at #ESPID2025! She shared insights on how clinical practice indicators changed before and after using our e-learning tool during the pilot phase 📊✨ #PediatricInfectiousDisease #AMS #IPC 022
pablorojo.bsky.social @pablorojo.bsky.social · 31/05/2025Excellent project, excellent first results! 041
pablorojo.bsky.social @pablorojo.bsky.social · 31/03/2025Happy to follow @pentafoundation.bsky.social in BLUESKY. Looking to disseminate more in this new channel about pediatric infectious diseases and pediatric global health! 010
pablorojo.bsky.social @pablorojo.bsky.social · 28/03/2025#SUPPORT project is up and running! Very proud that @globalpid.bsky.social is leading this capacity strengthening project! 010
pablorojo.bsky.social @pablorojo.bsky.social · 17/11/2024Probando BlueSky. Buscando una red social que me permita comunicarme de manera profesional y con valores éticos universales. Que no manipule ni disemine bulos. 010
